Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
51 results
- 3상모집 중단 (진행 중)· Hidradenitis SuppurativaA Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
리드: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple Sclerosis (RMS)Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
리드: 노바티스
- 3상모집 중단 (진행 중)· Hidradenitis SuppurativaA Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
리드: 노바티스
- 3상모집 중단 (진행 중)· Generalized Myasthenia GravisA Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
리드: 노바티스
- 3상모집 중단 (진행 중)· Polymyalgia RheumaticaOpen-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
리드: 노바티스
- 3상모집 중단 (진행 중)· Chronic Inducible UrticariaA Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
리드: 노바티스
- 3상모집 중단 (진행 중)· Follicular Lymphoma (FL)A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
리드: 노바티스
- 3상모집 중단 (진행 중)· Hyperlipoproteinemia (a)An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
리드: 노바티스
- 3상모집 중단 (진행 중)· Chronic Spontaneous Urticaria24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
리드: 노바티스
- 3상모집 중단 (진행 중)· Systemic Lupus ErythematosusPhase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
리드: 노바티스
- 3상모집 중단 (진행 중)· Primary Prevention of Atherosclerotic Cardiovascular DiseaseA Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
리드: 노바티스
- 3상모집 중단 (진행 중)· Systemic Lupus ErythematosusPhase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
리드: 노바티스
- 3상모집 중단 (진행 중)· Primary Immune Thrombocytopenia (ITP)Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
리드: 노바티스
- 3상모집 중단 (진행 중)· Primary Immune ThrombocytopeniaA Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
리드: 노바티스
- 3상모집 중단 (진행 중)· Warm Autoimmune Hemolytic Anemia (wAIHA)A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
리드: 노바티스
- 3상모집 중단 (진행 중)· Spinal Muscular Atrophy (SMA)Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
리드: 노바티스
- 3상모집 중단 (진행 중)· Chronic Spontaneous UrticariaAn Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib
리드: 노바티스
- 3상모집 중단 (진행 중)· Philadelphia Chromosome-Positive Chronic Myeloid LeukemiaA Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)
리드: 노바티스
- 3상모집 중단 (진행 중)· Sjogren SyndromeThree-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
리드: 노바티스
- 3상모집 중단 (진행 중)· Lupus NephritisSafety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
리드: 노바티스
- 3상모집 중단 (진행 중)· Coronary Artery DiseaseCoronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
리드: 노바티스
- 3상모집 중단 (진행 중)· Non-Small Cell Lung CancerStudy of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
리드: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)
리드: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)
리드: 노바티스
- 3상모집 중단 (진행 중)· Atherosclerotic Cardiovascular DiseaseStudy of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
리드: 노바티스
- 3상모집 중단 (진행 중)· Differentiated Thyroid Cancer (DTC)Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer
리드: 노바티스
- 3상모집 중단 (진행 중)· Chronic Myeloid Leukemia (CML) Philadelphia Chromosome PositiveA Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
리드: 노바티스
- 3상모집 중단 (진행 중)· Multiple Sclerosis (MS)Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
리드: 노바티스
- 3상모집 중단 (진행 중)· Primary IgA NephropathyA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
리드: 노바티스
- 3상모집 중단 (진행 중)· Advanced Breast CancerTrastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
협력: 노바티스
- 3상모집 중단 (진행 중)· Paroxysmal Nocturnal HemoglobinuriaLong-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
리드: 노바티스
- 3상모집 중단 (진행 중)· Prostatic Neoplasms177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
리드: 노바티스
- 3상모집 중단 (진행 중)· MyelofibrosisPhase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
리드: 노바티스
- 3상모집 중단 (진행 중)· Advanced HER2+Breast CancerStudy of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation
리드: 노바티스
- 3상모집 중단 (진행 중)· Spinal Muscular Atrophy Type ILong-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
리드: 노바티스
- 3상모집 중단 (진행 중)· Sickle Cell Disease (SCD)Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
리드: 노바티스
- 3상모집 중단 (진행 중)· MigraineEfficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
리드: 암젠 · 협력: 노바티스
- 3상모집 중단 (진행 중)· Breast Cancer FemaleAdj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC
협력: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisLong-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
리드: 노바티스
- 3상모집 중단 (진행 중)· Early Breast CancerA Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
리드: 노바티스
- 3상모집 중단 (진행 중)· Atherosclerotic Cardiovascular DiseaseA Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
협력: 노바티스
- 3상모집 중단 (진행 중)· Multiple SclerosisSafety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
리드: 노바티스
- 3상모집 중단 (진행 중)· SarcomaCombined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
협력: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.